How Should Balanced Translocation Carriers Choose IVF? A PGT-SR Guide for Kyrgyzstan and Georgia

People who carry balanced translocations, inversions, or other chromosomal structural abnormalities may be healthy in everyday life. However, they may experience recurrent pregnancy loss, abnormal embryos, or unexplained infertility when trying to conceive. Once a karyotype report reveals a structural variation, many families ask whether they need PGT-SR, PGT-A, or PGT-M.

　　The answer begins with identifying the source of risk. These tests serve different purposes and should not be treated as interchangeable.

Why Genetic Counseling Matters for Balanced Translocations

　　A balanced translocation usually involves an exchange of chromosomal segments without an obvious loss or gain of genetic material in the carrier. This is why the carrier may have no noticeable health concerns.

　　During embryo formation, however, some embryos may carry unbalanced chromosomal segments. Genetic counseling considers the type and breakpoints of the translocation, previous reproductive history, embryo testing results, and both partners’ medical findings to help define the appropriate assessment path.

What Is the Difference Between PGT-SR, PGT-A, and PGT-M?

　　PGT-SR is mainly used for balanced translocations, inversions, and other chromosomal structural rearrangements. It assesses whether an embryo may have an imbalance related to a parent’s structural rearrangement.

　　PGT-A mainly evaluates common numerical chromosome abnormalities, such as an extra or missing chromosome. It does not replace PGT-SR when a specific structural rearrangement is known.

　　PGT-M is designed for known single-gene conditions, such as thalassemia, spinal muscular atrophy, or hereditary hearing loss. It requires confirmation of the disease-causing variant and a family-specific testing strategy.

　　In short, balanced translocation carriers usually discuss PGT-SR first. Whether additional testing is appropriate depends on age, reproductive history, embryo results, and medical advice.

Prepare the Right Records Before Starting a Cycle

　　Families are generally advised to prepare both partners’ karyotype reports, prior embryo testing or pregnancy-loss records, genetic counseling notes, and any relevant family information.

　　More complete records can help the laboratory assess test feasibility and reduce avoidable delays after a cycle begins. PGT-SR can provide important information about known structural risks, but it is not 100% accurate and cannot guarantee a healthy child. Prenatal confirmation, NT screening, and detailed ultrasound examinations should still follow the treating doctor’s recommendations.

Kyrgyzstan and Georgia: Two Coordinated Care Pathways

　　In Kyrgyzstan, pre-treatment record review, medical assessment, laboratory testing, and cross-border travel arrangements can be coordinated in stages. For families with balanced translocations or previous abnormal embryo findings, completing karyotype and genetic documentation early can make the treatment timeline clearer.

　　In Georgia, reproductive medicine, embryology laboratory coordination, genetic testing communication, and cross-border care management can also be considered as a connected pathway. For families who want to understand laboratory conditions, test scope, and document preparation before starting, structured stage management can reduce uncertainty.

　　Whichever destination is considered, the testing approach, eligibility, travel requirements, and clinical standards should be confirmed through medical evaluation and final signed documents.

Tulip and GEBE: Assess First, Then Plan the Cycle

　　Tulip International Fertility Center, located in Bishkek, Kyrgyzstan, can help families organize karyotype reports, previous reproductive records, and genetic counseling needs before moving into medical evaluation, laboratory communication, and cycle coordination.

　　GEBE UNIVERSE Fertility Center, located in Tbilisi, Georgia, can support families with reproductive assessment, embryology laboratory coordination, genetic-testing communication, and staged care planning for chromosomal structural risks.

　　Both centers emphasize confirming the type of structural rearrangement, test feasibility, and laboratory requirements before starting a cycle. The final testing scope, timing, and costs should always be determined through individual medical and laboratory assessment.

　　If you are considering IVF with PGT-SR because of a balanced translocation, inversion, or recurrent pregnancy loss, prepare your karyotype report and previous records first, then explore an assessment pathway with Tulip International Fertility Center in Kyrgyzstan or GEBE UNIVERSE in Georgia.

For further information about overseas assisted reproduction procedures, interpretation of test reports, or evaluation of personalised treatment plans, please do not hesitate to contact us for one-on-one systematic consultation and professional guidance.

🌐 Official Website: Click here to access the consultation page
📧 Official Email: tulipivf@gmail.com
💬 Official WeChat: Tulip_EnoChan
☎️ Official Phone Numbers: 138-8085-7038 ｜ 400-060-0670